Vanguard Group Inc Guardant Health, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,168,020 shares of GH stock, worth $670 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,168,020
Previous 12,081,377
0.72%
Holding current value
$670 Million
Previous $515 Million
23.04%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding GH
# of Institutions
415Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$234 Million7.85% of portfolio
-
Invesco Ltd. Atlanta, GA3.56MShares$196 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...